Subscribe to RSS
Download PDF
DOI: 10.1055/a-1471-8947
Anti-inflammatory and Anti-arthritic Activities of Aqueous Extract and Flavonoids from Tripodanthus acutifolius Leaves in Mice Paw Oedema
Abstract
Tripodanthus acutifolius, commonly known as Jamillo, is an herbal remedy used in traditional Andean medicine to treat joint problems, such as sprains, dislocations, and rheumatic pain. This study aimed to evaluate the in vitro and in vivo anti-inflammatory and anti-arthritic activity of the aqueous extract and isolated compounds of T. acutifolius. A bioguided phytochemical analysis based on NMR/MS was performed to identify the compounds of the aqueous extract from T. acutifolius. The anti-inflammatory and anti-arthritic activity were evaluated by measuring inflammatory parameters (TNF-α, C-reactive protein, and fibrinogen) in murine models. The chemical structure determination led to the identification of four flavonoids: (E)-2’,4’-dihydroxy-6’-methoxy-chalcone (1), 6,2’,4’-trimethoxyflavone (2), 5,3’,4’-trihydroxy-6,7,8-trimethoxyflavone (3), and 5,4’-dihydroxy-6,7,8-trimethoxyflavone (4). All compounds inhibited the production of TNF-α in the RAW 264.7 cell line, with IC50 values of 0.78, 1.43, 5.73, and 9.71 μM, respectively. In addition, all flavonoids decreased the levels of TNF-α, C-reactive protein, and fibrinogen at a concentration of 5 mg/kg in murine models. Our research shows that these compounds isolated from T. acutifolius have anti-inflammatory and anti-arthritic properties, providing scientific evidence for the traditional use of this plant species.
Key words
Loranthaceae - Tripodanthus acutifolius - flavonoids - anti-inflammatory - anti-arthritic - TNF-αPublication History
Received: 13 February 2021
Received: 21 March 2021
Accepted: 30 March 2021
Article published online:
27 May 2021
© 2021. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).
Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany
-
References
- 1 Croft AP, Campos J, Jansen K, Turner JD, Marshall J, Attar M, Savary L, Wehmeyer C, Naylor AJ, Kemble S, Begum J, Dürholz K, Perlman H, Barone F, McGettrick HM, Fearon DT, Wei K, Raychaudhuri S, Korsunsky I, Brenner MB, Buckley CD. Distinct fibroblast subsets drive inflammation and damage in arthritis. Nature 2019; 570: 246-251
- 2 Apaza Ticona L, Rumbero Sánchez A, Sánchez Sánchez-Corral J, Iglesias Moreno P, Ortega Domenech M. Anti-inflammatory, pro-proliferative and antimicrobial potential of the compounds isolated from Daemonorops draco (Willd.) Blume. J Ethnopharmacol 2020; 268: 113668
- 3 Kuprash DV, Nedospasov SA. Molecular and Cellular Mechanisms of Inflammation. Biochemistry 2016; 81: 1237-1239
- 4 McInnes IB, Schett G. The pathogenesis of rheumatoid arthritis. N Engl J Med 2011; 365: 2205-2219
- 5 Smolen JS, Aletaha D, McInnes IB. Rheumatoid arthritis. Lancet 2016; 388: 2023-2038
- 6 Liu-Bryan R. Synovium and the innate inflammatory network in osteoarthritis progression. Curr Rheumatol Rep 2013; 15: 323
- 7 Isomäki P, Punnonen J. Pro- and anti-inflammatory cytokines in rheumatoid arthritis. Ann Med 1997; 29: 499-507
- 8 Matsuno H, Yudoh K, Katayama R, Nakazawa F, Uzuki M, Sawai T, Yonezawa T, Saeki Y, Panayi GS, Pitzalis C, Kimura T. The role of TNF-alpha in the pathogenesis of inflammation and joint destruction in rheumatoid arthritis (RA): A study using a human RA/SCID mouse chimera. Rheumatology (Oxford) 2002; 41: 329-337
- 9 Popa C, Netea MG, van Riel PL, van der Meer JW, Stalenhoef AF. The role of TNF-alpha in chronic inflammatory conditions, intermediary metabolism, and cardiovascular risk. J Lipid Res 2007; 48: 751-762
- 10 Zelová H, Hošek J. TNF-α signalling and inflammation: interactions between old acquaintances. Inflamm Res 2013; 62: 641-651
- 11 Saidenberg-Kermanac’h N, Corrado A, Lemeiter D, deVernejoul MC, Boissier MC, Cohen-Solal ME. TNF-alpha antibodies and osteoprotegerin decrease systemic bone loss associated with inflammation through distinct mechanisms in collagen-induced arthritis. Bone 2004; 35: 1200-1207
- 12 Maini RN, Elliott MJ, Brennan FM, Feldmann M. Beneficial effects of tumour necrosis factor-alpha (TNF-alpha) blockade in rheumatoid arthritis (RA). Clin Exp Immunol 1995; 101: 207-212
- 13 Bournia VK, Kitas G, Protogerou AD, Sfikakis PP. Impact of non-steroidal anti-inflammatory drugs on cardiovascular risk: Is it the same in osteoarthritis and rheumatoid arthritis?. Mod Rheumatol 2017; 27: 559-569
- 14 Moelants EA, Mortier A, Van Damme J, Proost P. Regulation of TNF-α with a focus on rheumatoid arthritis. Immunol Cell Biol 2013; 91: 393-401
- 15 Yamanaka H. TNF as a Target of Inflammation in Rheumatoid Arthritis. Endocr Metab Immune Disord Drug Targets 2015; 15: 129-134
- 16 Radner H, Aletaha D. Anti-TNF in rheumatoid arthritis: an overview. Wien Med Wochenschr 2015; 165: 3-9
- 17 Downey C. Serious infection during etanercept, infliximab and adalimumab therapy for rheumatoid arthritis: A literature review. Int J Rheum Dis 2016; 19: 536-550
- 18 Stevenson M, Archer R, Tosh J, Simpson E, Everson-Hock E, Stevens J, Hernandez-Alava M, Paisley S, Dickinson K, Scott D, Young A, Wailoo A. Adalimumab, etanercept, infliximab, certolizumab pegol, golimumab, tocilizumab and abatacept for the treatment of rheumatoid arthritis not previously treated with disease-modifying antirheumatic drugs and after the failure of conventional disease-modifying antirheumatic drugs only: Systematic review and economic evaluation. Health Technol Assess 2016; 20: 1-610
- 19 Vashisht P, O’dell J. Not all TNF inhibitors in rheumatoid arthritis are created equal: Important clinical differences. Expert Opin Biol Ther 2017; 17: 989-999
- 20 Dixon W, Felson DT. Is anti-TNF therapy safer than previously thought?. J Am Med Assoc 2011; 306: 2380-2381
- 21 Verma PK, Bala M, Kumar N, Singh B. Therapeutic potential of natural products from terrestrial plants as TNF-α antagonist. Curr Top Med Chem 2012; 12: 1422-1435
- 22 Nayak BN, Kaur G, Buttar HS. TNF-α modulation by natural bioactive molecules in mouse RAW 264.7 macrophage cells. J Complement Integr Med 2016; 13: 1-7
- 23 Paul AT, Gohil VM, Bhutani KK. Modulating TNF-alpha signaling with natural products. Drug Discov Today 2006; 11: 725-732
- 24 Folmer F, Jaspars M, Solano G, Cristofanon S, Henry E, Tabudravu J, Black K, Green DH, Küpper FC, Aalbersberg W, Feussner K, Dicato M, Diederich M. The inhibition of TNF-alpha-induced NF-kappaB activation by marine natural products. Biochem Pharmacol 2009; 78: 592-606
- 25 Saggese D, Saggese AA. Yerbas Medicinales Argentinas: breves apuntes de las propiedades de las mismas e indicaciones para su uso.. Rosario, Santa Fe-Argentina: Antognazzi & Cia, SRL; 1950: 65-66
- 26 Alice CB, Vargas VM, Silva GA, de Siqueira NC, Schapoval EE, Gleye J, Henriques JA, Henriques AT. Screening of plants used in south Brazilian folk medicine. J Ethnopharmacol 1991; 35: 165-171
- 27 Muñoz V, Sauvain M, Bourdy G, Arrázola S, Callapa J, Ruiz G, Choque J, Deharo E. A search for natural bioactive compounds in Bolivia through a multidisciplinary approach. Part III. Evaluation of the antimalarial activity of plants used by Alteños Indians. J Ethnopharmacol 2000; 71: 123-131
- 28 Macia MJ, Garcia E, Vidaurre PJ. An ethnobotanical survey of medicinal plants commercialized in the markets of La Paz and El Alto, Bolivia. J Ethnopharmacol 2005; 97: 337-350
- 29 Justo-Chipana M, Moraes RM. Medicinal plants marketed by chifleras of La Paz and El Alto cities (Bolivia). Ecol Boliv 2015; 50: 66-90
- 30 Soberón JR, Sgariglia MA, Melina A, Sampietro DA, Quiroga EN, Vattuone MA.. Isolation, identification and determination of the antioxidant activity of a glycoflavonoid from Tripodanthus acutifolius (Ruiz & Pavón) Van Tieghem. Bol Latinoam Caribe Plant Med Aromaticas 2007; 6: 276-277
- 31 Soberón JR, Sgariglia MA, Sampietro DA, Quiroga EN, Vattuone MA. Study of anti-inflammatory activity of metabolites isolated from Rev. Jovens Pesqui . Mol Med Med Chem 2010; 21: 88-90
- 32 Grüner JM, de Souza TK, Benitez LB, da Silva CM. Análise do perfil fitoquímico de Tripodanthus acutifolius (Ruiz & Pavón) Tieghem, Loranthaceae. Rev Jovens Pesqui Santa Cruz do Sul 2012; 1: 9-17
- 33 Apaza Ticona L, Serban AM, Cabanillas AH, Villacampa A, Rumbero Sánchez A. Flavonoids of Tripodanthus acutifolius inhibit TNF-α production in LPS-activated THP-1 and B16-F10 cells. J Ethnopharmacol 2019; 242: 112036
- 34 Chan FKM, Moriwaki K, De Rosa MJ. Detection of necrosis by release of lactate dehydrogenase (LDH) activity. Methods Mol Biol 2013; 979: 65-70
- 35 Arnott JA, Planey SL. The influence of lipophilicity in drug discovery and design. Expert Opin Drug Discov 2012; 10: 863-875
- 36 Ahmad S, Israf DA, Lajis NH, Shaari K, Mohamed H, Wahab AA, Ariffin KT, Hoo WY, Aziz NA, Kadir AA, Sulaiman MR, Somchit MN.. Cardamonin, inhibits pro-inflammatory mediators in activated RAW 264.7 cells and whole blood. Eur J Pharmacol 2006; 538: 188-194
- 37 Takahashi A, Yamamoto N, Murakami A. Cardamonin suppresses nitric oxide production via blocking the IFN-γ/STAT pathway in endotoxin-challenged peritoneal macrophages of ICR mice. Life Sci 2011; 89: 337-342
- 38 Fehrenbacher JC, Vasko MR, Duarte DB. Models of inflammation: carrageenan- or complete Freund’s adjuvant-induced edema and hypersensitivity in the rat. Curr Protoc Pharmacol 2012; 56: 5.4.1-5.4.4
- 39 Mateen S, Zafar A, Moin S, Khan AQ, Zubair S. Understanding the role of cytokines in the pathogenesis of rheumatoid arthritis. Clin Chim Acta 2016; 455: 161-171
- 40 Kumar LD, Karthik R, Gayathri N, Sivasudha T. Advancement in contemporary diagnostic and therapeutic approaches for rheumatoid arthritis. Biomed Pharmacother 2016; 79: 52-61
- 41 McNamee K, Williams R, Seed M. Animal models of rheumatoid arthritis: How informative are they?. Eur J Pharmacol 2015; 759: 278-286
- 42 Ferrándiz ML, Alcaraz MJ. Anti-inflammatory activity and inhibition of arachidonic acid metabolism by flavonoids. Agents Actions 1991; 32: 283-288
- 43 Tena Pérez V, Apaza Ticona L, Serban AM, Acero GJ, Rumbero Sánchez A. Synthesis and biological screening of a library of macamides as TNF-α inhibitors. RSC Med Chem. 2020. 11. 1196-1209
- 44 Abd-Allah A, El-Deen N, Mohamed W, Naguib FM. Mast cells and pro-inflammatory cytokines roles in assessment of grape seeds extract anti-inflammatory activity in rat model of carrageenan-induced paw edema. Iran J Basic Med Sci 2018; 21: 97-107
- 45 Clauss A. Gerinnungsphysiologische schnellmethode zur bestimmung des fibrinogens. Acta Haematol 1957; 17: 237-246
- 46 Newbould BB. Chemotherapy of arthritis induced in rats by mycobacterial adjuvant. Br J Pharmacol 1963; 21: 127-136